💠 Atherosclerosis
Main Target for Atherosclerosis Treatment | Lowering LDL-cholesterol levels in blood
Main Target for Atherosclerosis Treatment
Lowering LDL-cholersterol levels in blood
💠 Treatment of Atherosclerosis
Paradigm Shift | From Cholesterol Suppression to PCSK9 Inhibition
Atherosclerosis Treatment
from Cholesterol suppression to PCSK9 inhibition
💠 Role of PCSK9 in Atherosclerosis
PCSK9 | Obstructs the recycling of LDL-receptors(LDL-R)
PCSK9
obstruct the recycling of LDL-receptor(LDL-R)
💠 Needs for Novel Oral Innovative Drug
Limitations of current Treatment | Need for an oral, small-molecule PCSK9 inhibitor
PCSK9 Limitations of Current Treatment
Need for an oral, small-molecule PCSK9 inhibitor
💠 Novel PCSK9 inhibitors
Hyperlipidemia treatment market | ELEO's superior competitiveness that transcends comparison
💠 Novel PCSK9 inhibitor
Hyperlipidemia Treatment Market
C1's superior competitiveness that transcends comparison
